IAMA 097
Alternative Names: IAMA-097Latest Information Update: 03 Aug 2022
Price :
$50 *
At a glance
- Originator IAMA
- Class Small molecules
- Mechanism of Action Sodium chloride symporter Inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Autistic disorder
Most Recent Events
- 29 Jun 2022 Early research in Autistic disorder in France (unspecified route) before June 2022
- 30 Mar 2022 IAMA Therapeutics, Italian Institute of Technology and Telethon Foundation enters into licensing agreement for the research, development, manufacturing, and commercialisation of selective sodium potassium chloride cotransporter (NKCC1)-inhibitors for neurological disorders